Clinical trial
A Study Assessing the Efficacy and Safety of Deferasirox in Patients With…
NCT00171821 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00171821 |
|---|---|
| Title | A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload |
| Official title | A One Year, Open-label, Single-arm, Multi-center Trial Evaluating the Efficacy and Safety of Oral ICL670 (20 mg/kg/Day) in Patients Diagnosed With Transfusion-dependent Iron Overload |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Transfusion-dependent Iron Overload |
| Intervention type | Drug |
| Interventions | Deferasirox |
| Enrollment | 1,784 |
| Start date | Apr 1, 2005 |
| Primary completion | May 1, 2009 |
| Completion | Jul 1, 2010 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 11, 2020 |
| Countries | Australia, Austria, Belgium, China, Denmark, Egypt, France, Germany, Greece, Hong Kong, Israel, Italy and 11 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: